Patrick Fenningham, chief product officer and executive vice president, EIR Healthcare, Philadelphia
Fenningham, 31, started his career at Johnson & Johnson as a biomedical engineer, before earning an MBA and relocating his talents to Siemens Healthcare, where he focused on market analytics and product management. He went on to become the head of commercial operations at Thomson Reuters Intellectual Property and Science (now Clarivate Analytics). Today, his work includes developing an enterprise-wide product strategy, defining research and development roadmaps, and driving innovation to help strengthen EIR’s position as a leader in modular technology in the healthcare industry.
MHE: Why did you choose your profession?
Fenningham: Ever since my grandfather died of cardiac complications when I was 12 years old, I wanted to understand why it happened. This drove me to enter the medical field. I began my college education by taking the pre-med cardiology track. While there, my interests transformed from cardiology to biomedical engineering. My goal grew to helping patients with all kinds of ailments. I am now focused on improving the overall healthcare experience for patients and caregivers.
MHE: What has been your biggest learning experience in the industry? What did it teach you?
Fenningham: If you truly want to make a difference in your space, sit with the people who actually do the work. Early on in my career, I found that those who really knew what was going on with the products and services within a company are the boots on the ground, not the executives or board of directors. As I climbed the ladder into management roles, I always felt my greatest asset was my ability to connect with the people on the front lines. They can tell you everything you need to know if given the chance.
MHE: What change would you like to see in healthcare in the next five to 10 years?
Fenningham: I would like to see an open-source collaboration across the industry using data analytics to create predictive indicators that will be used to directly impact patient outcomes.
MHE: If you could sit down to dinner with anyone involved in healthcare who would it be?
Fenningham: Babak Parviz, PhD, who heads the Amazon Grand Challenge, a division of Amazon primarily focused on cancer research and electronic health record technology. I find it incredibly fascinating when very successful and well-educated groups outside of the healthcare world bring a new perspective to the industry. Understanding his high-level approach on how he plans to tackle healthcare would be exciting.